Answers are grounded in this paper and cite their sources.
Both enantiomers of 4-N-[1-(5-Fluoro-2-methoxyphenyl)ethyl]carbamoylmethylbenzoic acid display hypoglycemic activity. The more potent (S) enantiomer is approximately equipotent with the acylaminoethylbenzoic acids of the type HB 699 (Figure 1; Table I). Observations are given that suggest that these benzoic acids act at the same receptor as the hypoglycemic sulfonylureas and sulfonylaminopyrimidines and further that this receptor includes important binding sites.
No takes yet. Share an insight, caveat, or question.
Rufer et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: